Promeneur D, Bankir L, Hu M C, Trinh-Trang-Tan M M
Institut National de la Santé et de la Recherche Médicale, Unité 90, Hôpital Necker, Paris, France.
J Am Soc Nephrol. 1998 Aug;9(8):1359-66. doi: 10.1681/ASN.V981359.
In the kidney, facilitated urea transport in precise vascular and tubular structures is mainly involved in water conservation. Three urea transporters have been cloned: UT2-long expressed in terminal inner medullary collecting duct (IMCD), UT2-short expressed in thin descending limb, and UT11 in descending vasa recta. The effect of arginine vasopressin (AVP) administration on mRNA expression of these three transporters was examined in Brattleboro rats with diabetes insipidus. V2 effects were discriminated from combined V1 + V2 effects by comparing treatments with 1-deamino-8-D-AVP (dDAVP) (selective V2 agonism) and AVP (V1 and V2 agonism). Acute and chronic treatments were studied. Abundance of specific mRNA was assessed by quantitative Northern blot analysis of RNA extracted from two regions of inner stripe of outer medulla and from two regions of inner medulla (IM). The results show that mRNA of these urea transporters are differently regulated by AVP. (1) Long-term treatment with either AVP or dDAVP does not alter UT2-long mRNA in tip IM (terminal IMCD) except for a transient initial decrease. (2) Unlike AVP, dDAVP induces the appearance of significant expression of UT2-long mRNA in base IM (initial IMCD), indicating a major V2 effect. (3) UT2-short mRNA in deep inner stripe of outer medulla and base IM (thin descending limb of short and long loops, respectively) is progressively upregulated with duration of AVP or dDAVP treatment. (4) The much higher changes in UT2-long and UT2-short induced by dDAVP compared with AVP suggest that they are dependent mainly on V2 agonism, and likely attenuated by V1 agonism. (5) UT11 mRNA expression in tip IM is equally depressed by AVP and dDAVP, indicating that this vascular transporter is also influenced by AVP and/or urine-concentrating activity, via an indirect mechanism that remains to be determined.
在肾脏中,尿素在精确的血管和肾小管结构中的易化转运主要参与水的重吸收。已克隆出三种尿素转运体:在终末内髓集合管(IMCD)中表达的UT2-long、在细降支中表达的UT2-short以及在直小血管降支中表达的UT11。在患有尿崩症的布拉特洛维大鼠中,研究了给予精氨酸加压素(AVP)对这三种转运体mRNA表达的影响。通过比较用1-去氨基-8-D-精氨酸加压素(dDAVP)(选择性V2激动剂)和AVP(V1和V2激动剂)进行的治疗,区分了V2效应与V1 + V2联合效应。研究了急性和慢性治疗。通过对从外髓内带的两个区域和内髓(IM)的两个区域提取的RNA进行定量Northern印迹分析,评估特定mRNA的丰度。结果表明,这些尿素转运体的mRNA受AVP的调节方式不同。(1)长期用AVP或dDAVP治疗,除了最初有短暂下降外,不会改变尖端IM(终末IMCD)中的UT2-long mRNA。(2)与AVP不同,dDAVP诱导基部IM(起始IMCD)中UT2-long mRNA出现显著表达,表明主要是V2效应。(3)外髓深内带和基部IM(分别为短环和长环的细降支)中的UT2-short mRNA随着AVP或dDAVP治疗时间的延长而逐渐上调。(4)与AVP相比,dDAVP诱导的UT2-long和UT2-short变化要高得多,这表明它们主要依赖于V2激动作用,并且可能会被V1激动作用减弱。(5)尖端IM中的UT11 mRNA表达同样受到AVP和dDAVP的抑制,表明这种血管转运体也受到AVP和/或尿液浓缩活性的影响,其间接机制尚待确定。